HomeInsightsStock Comparison

Piramal Pharma Ltd vs Sms Pharmaceuticals Ltd Stock Comparison

Piramal Pharma Ltd vs Sms Pharmaceuticals Ltd Stock Comparison

Last Updated on: May 03, 2025

Key Highlights

  • The Latest Trading Price of Piramal Pharma Ltd is ₹ 211.2 as of 02 May 15:30.
  • The P/E Ratio of Piramal Pharma Ltd changed from 991.5 on March 2024 to 991.5 on March 2024 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of SMS Pharmaceuticals Ltd changed from 7.1 on March 2020 to 30.2 on March 2024 . This represents a CAGR of 33.58% over 5 years.
  • The Market Cap of Piramal Pharma Ltd changed from ₹ 8165 crore on March 2023 to ₹ 17052 crore on March 2024 . This represents a CAGR of 44.51% over 2 yearsThe Market Cap of SMS Pharmaceuticals Ltd changed from ₹ 225.6 crore on March 2020 to ₹ 1507 crore on March 2024 . This represents a CAGR of 46.21% over 5 years.
  • The revenue of Piramal Pharma Ltd for the Dec '24 is ₹ 2233 crore as compare to the Sep '24 revenue of ₹ 2320 crore. This represent the decline of -3.74% The revenue of SMS Pharmaceuticals Ltd for the Dec '24 is ₹ 175.48 crore as compare to the Sep '24 revenue of ₹ 198.05 crore. This represent the decline of -11.4%.
  • The ebitda of Piramal Pharma Ltd for the Dec '24 is ₹ 366.92 crore as compare to the Sep '24 ebitda of ₹ 419.98 crore. This represent the decline of -12.63% The ebitda of SMS Pharmaceuticals Ltd for the Dec '24 is ₹ 35.34 crore as compare to the Sep '24 ebitda of ₹ 32.77 crore. This represent the growth of 7.84%.
  • The net profit of Piramal Pharma Ltd changed from ₹ -98.58 crore to ₹ 3.68 crore over 7 quarters. This represents a CAGR of NaN% The net profit of SMS Pharmaceuticals Ltd changed from ₹ 8.81 crore to ₹ 17.08 crore over 7 quarters. This represents a CAGR of 45.98% .
  • The Dividend Payout of Piramal Pharma Ltd changed from 18.07 % on March 2022 to 3.72 % on March 2024 . This represents a CAGR of -40.95% over 3 yearsThe Dividend Payout of SMS Pharmaceuticals Ltd changed from 6.48 % on March 2020 to 6.86 % on March 2024 . This represents a CAGR of 1.15% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Piramal Pharma Ltd

  • Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries.
  • It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India.
  • In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. PPL is a leading pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.
  • It operate under three business verticals - Piramal Pharma Solutions, an integrated contract development and manufacturing organization (CDMO) having a product suite in niche areas such as highly potent Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), antibody drug conjugates, potent sterile injectable, hormonal oral solid dosage forms, biologics and vaccines; Piramal Critical Care, a complex hospital generics (CHG) business in the areas of inhalation anaesthesia, injectable anaesthesia and pain management, intrathecal therapy and other injectable; and India consumer healthcare (ICH) business, selling well-known OTC brands.

About SMS Pharmaceuticals Ltd

  • SMS Pharmaceuticals Limited was incorporated in December, 1987.
  • The company is engaged in the business of manufacturing of Active Pharma Ingredients and their intermediates.
  • Apart from R &D Center at Gagillapur, Hyderabad, the company is having manufacturing facilities at Bachupally, Hyderabad and also at Kandivalasa Village in Vijayanagaram District of Andhra Pradesh.
  • Its business activity is a single primary business segment of 'Bulk Drugs'. During the year 2015, the company has re-enforced its fundamental strength of FDA compliant facilities by successfully completing the US FDA audits at Kandivalasa and Bachupally facilities. During the year 2015, the company filed 9 Drug Master Files and total DMFs filed up to 31 March 2015 are 24. During the year 2014-15, the Company acquired 12,25,900 equity shares of Rs.

Piramal Pharma Ltd News Hub

News

Piramal Pharma to conduct board meeting

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 14 May 2025...

Read more

30 Apr 2025 10:45

News

Piramal Pharma's Telangana unit starts production of general anesthesia drug Sevoflurane

This was achieved by creating capacity for Sevoflurane manufacture at the Digwal facility ...

Read more

02 Apr 2025 11:25

News

Piramal Pharma Ltd Spurts 3.8%

Piramal Pharma Ltd rose 3.8% today to trade at Rs 229.65. The BSE Healthcare index is up 0...

Read more

21 Mar 2025 09:30

News

Piramal Pharma declines after US FDA issues Form 483 with 6 observations to Turbhe unit

In a regulatory filing made after market hours yesterday, the pharmaceutical company state...

Read more

19 Feb 2025 09:37

News

Piramal Pharma Q3 PAT drops 64% YoY to Rs 4 crore

Profit before tax stood at Rs 66.80 crore in the December 2024 quarter, registering a grow...

Read more

29 Jan 2025 11:53

News

Piramal Pharma launches Chlorpromazine Hydrochloride in US

Chlorpromazine Hydrochloride Injection is a medicine used to treat various disorders such ...

Read more

23 Jan 2025 09:38

SMS Pharmaceuticals Ltd News Hub

News

SMS Pharmaceuticals' Unit VII receives WHO Geneva prequalification

SMS Pharmaceuticals announced that Unit VII manufacturing facility in Visakhapatnam, Andhr...

Read more

02 May 2025 12:36

News

SMS Pharma gains after Hyderabad facility completes USFDA inspection

According to an exchange filing, the inspection was conducted from 17 March to 21 March 20...

Read more

24 Mar 2025 09:59

News

SMS Pharma's Hyderabad facility completes USFDA inspection with 1 observation

According to an exchange filing, the inspection was conducted from 17 March to 21 March 20...

Read more

22 Mar 2025 16:28

News

SMS Pharmaceuticals schedules board meeting

SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 Feb...

Read more

06 Feb 2025 16:50

News

SMS Pharmaceuticals to convene board meeting

SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 8 Nove...

Read more

02 Nov 2024 12:49

News

SMS Pharmaceuticals to conduct AGM

SMS Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be...

Read more

08 Aug 2024 14:06

SWOT Analysis Of Piramal Pharma Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of SMS Pharmaceuticals Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

2

T

BlinkX Score for Piramal Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for SMS Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Piramal Pharma Ltd and SMS Pharmaceuticals Ltd

Which company has a larger market capitalization, Piramal Pharma Ltd or SMS Pharmaceuticals Ltd?

Market cap of Piramal Pharma Ltd is 27,999 Cr while Market cap of SMS Pharmaceuticals Ltd is 2,123 Cr

What are the key factors driving the stock performance of Piramal Pharma Ltd and SMS Pharmaceuticals Ltd?

The stock performance of Piramal Pharma Ltd and SMS Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Piramal Pharma Ltd and SMS Pharmaceuticals Ltd?

As of May 3, 2025, the Piramal Pharma Ltd stock price is INR ₹211.2. On the other hand, SMS Pharmaceuticals Ltd stock price is INR ₹239.55.

How do dividend payouts of Piramal Pharma Ltd and SMS Pharmaceuticals Ltd compare?

To compare the dividend payouts of Piramal Pharma Ltd and SMS Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions